We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Zacks.com featured highlights include Halozyme Therapeutics, GigaCloud Technology, Lindblad Expeditions, Permian Resources and Chevron
Read MoreHide Full Article
For Immediate Release
Chicago, IL – October 19, 2026 – Stocks in this week’s article are Halozyme Therapeutics (HALO - Free Report) , GigaCloud Technology (GCT - Free Report) , Lindblad Expeditions Holdings (LIND - Free Report) , Permian Resources (PR - Free Report) and Chevron Corp. (CVX - Free Report) .
5 Stocks to Buy Using Relative Price Strength Strategy
U.S. equities continue to show resilience despite a volatile backdrop. The S&P 500 has faced pressure from weakness in AI-linked technology stocks, but rotation into other sectors suggests the market's underlying strength is broader than a handful of major names. Investor interest also remains supported by expectations for continued corporate growth.
Risks have not disappeared. Sticky inflation, elevated energy prices, uncertainty around interest rates and concerns over debt-funded AI investment could keep markets unsettled. Even so, easing Treasury yields and signs of recovery across global equities offer support for a mildly bullish U.S. market outlook. Demand tied to AI and cloud investment also remains an important long-term driver.
With market leadership shifting, investors may benefit from focusing on stocks that consistently outperform the S&P 500. Relative price strength therefore appears to be a useful strategy for identifying stronger opportunities in the current market.
At this stage, investors would be wise to consider companies such as Halozyme Therapeutics, GigaCloud Technology, Lindblad Expeditions Holdings, Permian Resources and Chevron Corp..
Relative Price Strength Strategy
Whether a stock has the potential to offer considerable returns is determined primarily by its earnings and valuation ratios. Simultaneously, it is essential to check whether its price performance exceeds its peers or the industry average.
Upon such comparison, if we find that a stock is unable to match up to wider sectoral growth despite having impressive earnings momentum or valuation multiples, it may be better to avoid it.
However, those outperforming their respective industries or benchmarks should be included in your portfolio since they have a higher chance of securing significant returns. Picking a stock that outperforms its peers ensures a winning option in your hands.
Then again, it is imperative that you determine whether or not an investment has relevant upside potential when considering stocks with significant relative price strength. Stocks delivering better than the S&P 500 for 1 to 3 months, at least, and having solid fundamentals, indicate room for growth and are the best way to go about this strategy.
Finally, it is crucial to find out whether analysts are optimistic about the upcoming earnings of these companies. In order to do this, we have added positive estimate revisions for the current quarter's (Q1) earnings to our screen. When a stock undergoes an upward revision, it leads to additional price gains.
Here are five of the 20 stocks that made it through the screen:
Halozyme Therapeutics: Halozyme Therapeutics is a biopharmaceutical company focused on the development and commercialization of novel treatments for oncology indications by targeting the tumor microenvironment. The company's expected EPS growth rate for three to five years is currently 32%, which compares favorably with the industry's growth rate of 21.9%. Halozyme Therapeutics has a VGM Score of A.
Over the past 60 days, the Zacks Consensus Estimate for Halozyme Therapeutics' 2026 earnings has moved up 5.1%. The Zacks Consensus Estimate for 2026 earnings indicates 112.1% growth. HALO shares have gained 81.7% in a year.
GigaCloud Technology: GigaCloud Technology operates a global B2B ecommerce platform connecting mainly Asian manufacturers with resellers in the United States, Europe and Japan through an integrated marketplace for product discovery, payments and logistics. The Zacks Consensus Estimate for GCT's 2026 earnings indicates 37.1% growth. GigaCloud Technology has a VGM Score of B.
GCT beat the Zacks Consensus Estimate for earnings in each of the last four quarters. It has a trailing four-quarter earnings surprise of roughly 42.1%, on average. GigaCloud Technology shares have gained 119.4% in a year.
Lindblad Expeditions Holdings: It is an adventure travel company focused on immersive trips by sea and land. The Zacks Consensus Estimate for 2026 earnings of Lindblad Expeditions indicates 175.9% growth. The company has a VGM Score of B.
LIND has a trailing four-quarter earnings surprise of roughly 222.3%, on average. Over the past 60 days, the Zacks Consensus Estimate for the expedition voyage operator's 2026 earnings has moved up from 17 cents per share to 22 cents. Lindblad Expeditions's shares have nearly tripled in a year.
Permian Resources: Headquartered in Midland, TX, it is an independent oil and gas producer focused on the Permian Basin. Permian Resources has a market capitalization of more than $20 billion. It has a VGM Score of A.
Notably, over the past 60 days, the Zacks Consensus Estimate for PR's 2026 earnings has gone up 8.4%. The Zacks Consensus Estimate for 2026 earnings of Permian Resources indicates 62.2% growth. PR shares have gained 95.3% in a year.
Chevron: Chevron is one of the largest publicly traded oil and gas companies in the world with operations that span almost every corner of the globe. The company's expected EPS growth rate for three to five years is currently 20.7%, which compares favorably with the industry's growth rate of 16.4%. CVX has a VGM Score of A.
Over the past 60 days, the Zacks Consensus Estimate for Chevron's 2026 earnings has moved up 10.5%. The Zacks Consensus Estimate for 2026 earnings indicates 140.5% growth. CVX shares have gained 44.6% in a year.
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
About Screen of the Week
Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine. But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.
Strong Stocks that Should Be in the News
Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.
View the Zacks #1 Rank List
Image: Bigstock
Zacks.com featured highlights include Halozyme Therapeutics, GigaCloud Technology, Lindblad Expeditions, Permian Resources and Chevron
For Immediate Release
Chicago, IL – October 19, 2026 – Stocks in this week’s article are Halozyme Therapeutics (HALO - Free Report) , GigaCloud Technology (GCT - Free Report) , Lindblad Expeditions Holdings (LIND - Free Report) , Permian Resources (PR - Free Report) and Chevron Corp. (CVX - Free Report) .
5 Stocks to Buy Using Relative Price Strength Strategy
U.S. equities continue to show resilience despite a volatile backdrop. The S&P 500 has faced pressure from weakness in AI-linked technology stocks, but rotation into other sectors suggests the market's underlying strength is broader than a handful of major names. Investor interest also remains supported by expectations for continued corporate growth.
Risks have not disappeared. Sticky inflation, elevated energy prices, uncertainty around interest rates and concerns over debt-funded AI investment could keep markets unsettled. Even so, easing Treasury yields and signs of recovery across global equities offer support for a mildly bullish U.S. market outlook. Demand tied to AI and cloud investment also remains an important long-term driver.
With market leadership shifting, investors may benefit from focusing on stocks that consistently outperform the S&P 500. Relative price strength therefore appears to be a useful strategy for identifying stronger opportunities in the current market.
At this stage, investors would be wise to consider companies such as Halozyme Therapeutics, GigaCloud Technology, Lindblad Expeditions Holdings, Permian Resources and Chevron Corp..
Relative Price Strength Strategy
Whether a stock has the potential to offer considerable returns is determined primarily by its earnings and valuation ratios. Simultaneously, it is essential to check whether its price performance exceeds its peers or the industry average.
Upon such comparison, if we find that a stock is unable to match up to wider sectoral growth despite having impressive earnings momentum or valuation multiples, it may be better to avoid it.
However, those outperforming their respective industries or benchmarks should be included in your portfolio since they have a higher chance of securing significant returns. Picking a stock that outperforms its peers ensures a winning option in your hands.
Then again, it is imperative that you determine whether or not an investment has relevant upside potential when considering stocks with significant relative price strength. Stocks delivering better than the S&P 500 for 1 to 3 months, at least, and having solid fundamentals, indicate room for growth and are the best way to go about this strategy.
Finally, it is crucial to find out whether analysts are optimistic about the upcoming earnings of these companies. In order to do this, we have added positive estimate revisions for the current quarter's (Q1) earnings to our screen. When a stock undergoes an upward revision, it leads to additional price gains.
Here are five of the 20 stocks that made it through the screen:
Halozyme Therapeutics: Halozyme Therapeutics is a biopharmaceutical company focused on the development and commercialization of novel treatments for oncology indications by targeting the tumor microenvironment. The company's expected EPS growth rate for three to five years is currently 32%, which compares favorably with the industry's growth rate of 21.9%. Halozyme Therapeutics has a VGM Score of A.
Over the past 60 days, the Zacks Consensus Estimate for Halozyme Therapeutics' 2026 earnings has moved up 5.1%. The Zacks Consensus Estimate for 2026 earnings indicates 112.1% growth. HALO shares have gained 81.7% in a year.
GigaCloud Technology: GigaCloud Technology operates a global B2B ecommerce platform connecting mainly Asian manufacturers with resellers in the United States, Europe and Japan through an integrated marketplace for product discovery, payments and logistics. The Zacks Consensus Estimate for GCT's 2026 earnings indicates 37.1% growth. GigaCloud Technology has a VGM Score of B.
GCT beat the Zacks Consensus Estimate for earnings in each of the last four quarters. It has a trailing four-quarter earnings surprise of roughly 42.1%, on average. GigaCloud Technology shares have gained 119.4% in a year.
Lindblad Expeditions Holdings: It is an adventure travel company focused on immersive trips by sea and land. The Zacks Consensus Estimate for 2026 earnings of Lindblad Expeditions indicates 175.9% growth. The company has a VGM Score of B.
LIND has a trailing four-quarter earnings surprise of roughly 222.3%, on average. Over the past 60 days, the Zacks Consensus Estimate for the expedition voyage operator's 2026 earnings has moved up from 17 cents per share to 22 cents. Lindblad Expeditions's shares have nearly tripled in a year.
Permian Resources: Headquartered in Midland, TX, it is an independent oil and gas producer focused on the Permian Basin. Permian Resources has a market capitalization of more than $20 billion. It has a VGM Score of A.
Notably, over the past 60 days, the Zacks Consensus Estimate for PR's 2026 earnings has gone up 8.4%. The Zacks Consensus Estimate for 2026 earnings of Permian Resources indicates 62.2% growth. PR shares have gained 95.3% in a year.
Chevron: Chevron is one of the largest publicly traded oil and gas companies in the world with operations that span almost every corner of the globe. The company's expected EPS growth rate for three to five years is currently 20.7%, which compares favorably with the industry's growth rate of 16.4%. CVX has a VGM Score of A.
Over the past 60 days, the Zacks Consensus Estimate for Chevron's 2026 earnings has moved up 10.5%. The Zacks Consensus Estimate for 2026 earnings indicates 140.5% growth. CVX shares have gained 44.6% in a year.
For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/3010078/5-stocks-to-buy-using-the-relative-price-strength-strategy
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
About Screen of the Week
Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine. But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.
Strong Stocks that Should Be in the News
Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.
Follow us on Twitter: https://www.twitter.com/zacksresearch
Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Contact: Jim Giaquinto
Company: Zacks.com
Phone: 312-265-9268
Email: pr@zacks.com
Visit: https://www.zacks.com/
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.